We are live on ! Find out more
KIN

Kindred Biosciences, Inc.
KIN

Delisted

KIN was delisted on the 27th of August, 2021.

Back to rankings

1 hedge funds and large institutions have $11K invested in Kindred Biosciences, Inc. in 2021 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 85 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more call options, than puts

Call options by funds: $2K | Put options by funds: $1K

99% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 85

99% less funds holding

Funds holding: 87 → 1 (-86)

100% less capital invested

Capital invested by funds: $280M → $11K (-$280M)

Holders
1
Holders Change
-86
Holders Change %
-98.85%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
85
Calls
$2K
Puts
$1K
Net Calls
+$1K
Net Calls Change
-$3.23M

Top Buyers

Rank Fund Capital Flow
1
CFO
CVA Family Office
Colorado
+$23K

Top Sellers

Rank Fund Capital Flow
1
PWAM
Park West Asset Management
California
-$55M
2
Millennium Management
Millennium Management
New York
-$25.2M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$17.3M
4
Fidelity International
Fidelity International
Bermuda
-$16.6M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
-$14.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
Goldman Sachs
26
Goldman Sachs
New York
– -$2.44M -265,635 Closed
GI
27
GAMCO Investors
Connecticut
– -$2.31M -252,067 Closed
Citigroup
28
Citigroup
New York
– -$2.27M -247,219 Closed
Two Sigma Advisers
29
Two Sigma Advisers
New York
– -$2.14M -233,000 Closed
Norges Bank
30
Norges Bank
Norway
– -$1.98M -215,850 Closed
Barclays
31
Barclays
United Kingdom
– -$1.6M -174,042 Closed
GCIA
32
Gabelli & Co Investment Advisers
New York
– -$1.51M -164,685 Closed
Jane Street
33
Jane Street
New York
– -$1.49M -162,930 Closed
State Street
34
State Street
Massachusetts
– -$1.37M -149,762 Closed
BCM
35
BCK Capital Management
Connecticut
– -$1.33M -145,000 Closed
Two Sigma Investments
36
Two Sigma Investments
New York
– -$1.2M -130,655 Closed
Qube Research & Technologies (QRT)
37
Qube Research & Technologies (QRT)
United Kingdom
– -$1.2M -130,476 Closed
New York State Common Retirement Fund
38
New York State Common Retirement Fund
New York
– -$1.09M -119,389 Closed
Northern Trust
39
Northern Trust
Illinois
– -$894K -97,490 Closed
PFMU
40
Privium Fund Management (UK)
United Kingdom
– -$825K -90,000 Closed
HF
41
HRT Financial
New York
– -$784K -85,534 Closed
GAI
42
General American Investors
New York
– -$701K -76,471 Closed
GC
43
Guggenheim Capital
Illinois
– -$696K -75,923 Closed
HM
44
Harvest Management
New York
– -$688K -75,000 Closed
UBS Group
45
UBS Group
Switzerland
– -$593K -64,750 Closed
SSA
46
Schonfeld Strategic Advisors
New York
– -$584K -63,700 Closed
JF
47
Jump Financial
Illinois
– -$566K -61,668 Closed
AllianceBernstein
48
AllianceBernstein
Tennessee
– -$500K -54,500 Closed
Susquehanna International Group
49
Susquehanna International Group
Pennsylvania
– -$495K -54,003 Closed
GCP
50
GSA Capital Partners
United Kingdom
– -$479K -52,257 Closed
1
2
3 4

KIN Hedge Fund Activity: Q3 2021 in Review

1 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Kindred Biosciences, Inc. (KIN) for Q3 2021, worth a combined $11K — down 100% from $280M a quarter earlier.

Sellers outnumbered buyers: 85 funds closed out of KIN and 1 opened new positions — a net loss of 84 holders — while 0 trimmed existing stakes and 0 added.

The largest buyer was CVA Family Office, opening a new position worth an estimated $23K. The largest seller was Park West Asset Management, exiting entirely with an estimated $55M sold.

  • 1 institutional investor held Kindred Biosciences, Inc. (KIN) as of Q3 2021, down from 87 in Q2 2021.
  • Funds reported $11K of Kindred Biosciences, Inc. stock for Q3 2021, down 100% quarter-over-quarter.
  • 1 fund opened new Kindred Biosciences, Inc. positions in Q3 2021 and 85 closed out, a net change of -84 holders.
  • The largest Kindred Biosciences, Inc. buyer in Q3 2021 was CVA Family Office, an estimated $23K added.
  • The largest Kindred Biosciences, Inc. seller in Q3 2021 was Park West Asset Management, an estimated $55M sold.

Based on aggregated 13F filings for Q3 2021.